跳至主要內容

【參展 #BGOV2023，用generative AI方案助中小企開拓數碼未來！】

數據顯示，全球AI市場預計將在2030年產生超過1.5億美元交易；隨著ChatGPT的公開測試，generative AI技術話題更席捲各行各業。「BUSINESS GOVirtual科技博覽及會議2023」堅持協助中小企實行數碼轉型，以開拓潛力無限的數碼商機。

今年7月，我們將於會展3樓舉行大型B2B「商業x科技」展覽，歡迎各AI人工智能公司參展，向8,000+潛在客戶展示科技方案，幫助客戶數碼轉型「落地」：http://bit.ly/3EwPRoS

（數據來源：Precedence Research）

此網誌的熱門文章

香港 Backlinks 網站， 中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站，對於香港網站未能精準地改善中文版 Google 排名，有見及此，有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務，在 100 多個高誠信度的新聞網站刊登文案，增加香港 Backlinks ，大大提升中文版 Google 排名。 新聞網站包括： https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:
閱讀更多

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration   BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht
閱讀更多

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park.   Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT).   Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination   Learn more: https://lnkd.in/gEGmc7Vz   Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/
閱讀更多